(MARCH 9, 2015) A study authored by Andrew Solomon, M.D., UVM associate professor of neurological sciences, and colleagues is featured in the Wall Street Journal blog “Pharmalot”. The post discusses Solomon's OnlineFirst article, titled "Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics,” in Multiple Sclerosis Journal. Link to the blog post here.